Pharmacokinetics and clinical efficacy of long-term epidural ropivacaine infusion in children

British Journal of Anaesthesia

Volumn 85, Issue 3, 2000, Pages 347-353

  Hansen, T G ^a,d   Ilett, K F ^b   Lim, S I ^a   Reid, C ^a   Hackett, L P ^c   Bergesio, R ^a  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c Western Australian Centre for Pathology and Medical Research   (Australia)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Anaesthetic techniques, epidural; Anaesthetics, local; Paediatric pharmacokinetics

Indexed keywords

ALIMEMAZINE; BUPIVACAINE; FENTANYL; ISOFLURANE; METOCLOPRAMIDE; NITROUS OXIDE; ONDANSETRON; OXYGEN; PARACETAMOL; PROPOFOL; ROPIVACAINE; SEVOFLURANE; VECURONIUM;

ANALGESIA; ANESTHESIA INDUCTION; ARTERIAL PRESSURE; ARTICLE; BOLUS INJECTION; BREATHING RATE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INFUSION; DRUG SAFETY; EPIDURAL CATHETER; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; MALE; NAUSEA; NEUROMUSCULAR BLOCKING; OXYGEN TENSION; PEDIATRIC ANESTHESIA; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PRURITUS; PULSE RATE; SCORING SYSTEM; SEDATION; VOMITING;

EID: 0033856342     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/85.3.347     Document Type: Article

References (33)

1. Ropivacaine
2. Acute toxicity of ropivacaine compared with that of bupivacaine
3. Central nervous system toxicity attributable to epidural ropivacaine hydrochloride
4. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine and placebo in volunteers
5. Ropivacaine in paediatric surgery: Preliminary results
6. Ropivacaine for central blocks in children
7. Comparison of ropivacaine with bupivacaine for paediatric caudal block
8. Ropivacaine 0.25% compared with bupivacaine 0.25% by the caudal route
9. The dose response of caudal ropivacaine in children
10. Pharmacokinetics of ropivacaine following caudal analgesia in children
11. Ropivacaine pharmacokinetics following paediatric caudal block: Preliminary results
12. Use of ropivacaine in postoperative infusions
13. Compartmental and non-compartmental pharmacokinetics
14. Ropivacaine 0.75% for extradural anaesthesia in elective Caesarian section: An open clinical and pharmacokinetic study in mother and neonate
15. Systemic absorption and block after epidural injection of ropivacaine in healthy volunteers
16. Pharmacokinetic and clinical study of ropivacaine and bupivacaine in women receiving extradural analgesia in labour
17. Efficacy and kinetics of extradural ropivacaine: Comparison with bupivacaine
18. Pharmacokinetics and efficacy of long-term epidural ropivacaine infusion for postoperative analgesia
19. Pharmacokinetics of three doses of epidural ropivacaine during hysterectomy and comparison with bupivacaine
20. Pharmacodynamics and pharmacokinetics of epidural ropivacaine in humans
21. Pharmacokinetics and analgesic effect of ropivacaine during continuous epidural infusion for postoperative pain relief
22. Toxicity of local anesthetics in infants and children
23. Pain relief for infants undergoing abdominal surgery: Comparison of infusions of i.v. morphine and extradural bupivacaine
24. 1-acid glycoprotein concentration in infants undergoing major surgery
25. Plasma bupivacaine concentrations associated with extradural infusions in babies
26. Serum concentrations of bupivacaine during prolonged continuous paravertebral infusion in young infants
27. Plasma concentrations of bupivacaine in neonates after continuous epidural infusion
28. Smaller children have greater bupivacaine concentrations after ilioinguinal block
29. Plasma concentrations of bupivacaine in young infants after continuous epidural infusion
30. Spinal anaesthesia in newborns: Total and free bupivacaine concentrations
31. Metabolism and excretion of ropivacaine in humans
32. Disposition kinetics of ropivacaine in humans